We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Hematopoietic Stem Cells Shown to Make Blood Vessels

By Biotechdaily staff writers
Posted on 11 Jun 2002
Bone marrow stem cells have been shown to have the capability of migrating to sites of blood vessel synthesis and maturing into blood vessel cells. More...
The finding was reported in the June 2002 online issue of Nature.

Scientists at the University of Florida (Gainesville, USA; www.ufl.edu) developed a strain of transgenic mice which produced hematopoietic stem cells that express a green fluorescent protein. Stem cells from these mice were transplanted into the bone marrow of another type of mice that were models for the human eye condition known as retinopathy. Retinopathy is a diabetes-related degenerative process that injures existing blood vessels and triggers the formation of new capillaries. The new capillaries actually foster additional damage.

The researchers found that the new blood vessels that developed in the retinopathic mice after transplant contained cells with the green fluorescent protein. As the only source of this protein was the transplanted bone marrow, this was proof that homatopoietic stem cells could give rise to endothelial blood vessel cells.

"We have shown for the first time that adult blood stem cells can function to make blood vessels. We now know blood vessels can be formed from a remote location--they're not just repaired at the site of injury,” said Dr. Edward Scott. "That means we can now explore how to block that from happening to try to prevent things like diabetic retinopathy or enhance that activity to promote new blood vessel formation or blood vessel repair.”



Related Links:
University of Florida

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Thyroid Test
Anti-Thyroid EIA Test
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.